Wells Fargo’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Wells Fargo’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$7K	–	7707
2020 Q4	$7K	Hold	30,000	–	–	﹤0.01%	6103
2020 Q3	$52K	Buy	30,000 +18,500	+161%	+$285K	﹤0.01%	5499
2020 Q2	$24K	Buy	+11,500	New	+$173K	﹤0.01%	5663

Wells Fargo's TBIO Position: Q3 2021 in Review

Wells Fargo sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 91,540 shares — an estimated $2.52M sold.

Wells Fargo first reported a position in TBIO in Q2 2018 and held it in 13 quarters. The position peaked at $3.35M in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Wells Fargo reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Wells Fargo sold 91,540 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.52M.
Wells Fargo first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
Wells Fargo's Translate Bio, Inc. Common Stock position peaked at $3.35M in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.